Evidence map›Paper›PMID 42693624›Full record

ArticleMicrobial biotechnology2026

A Lytic Bacteriophage Cocktail Attenuates Carbapenem-Resistant Klebsiella pneumoniae-Acinetobacter baumannii Mixed-Species Biofilms and Reshapes Transcriptional Responses.

Xuefang Ren, Rui Zhu, Yijiang Yang, Xiaojuan You, Liuxiang Wang, Guangyu Fu, Yehuan Zheng, Chunxia Wang, Zhentao Wang, Yongwei Li

Abstract read
In one paragraph

Article in Microbial biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xuefang RenThe Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, China.ORCID https://orcid.org/0009-0003-8299-3922
Rui ZhuThe Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, China.ORCID https://orcid.org/0009-0004-6319-222X
Yijiang YangDepartment of Statistical Sciences, University of Toronto, Toronto, Canada.ORCID https://orcid.org/0009-0001-6309-3529
Xiaojuan YouThe Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, China.ORCID https://orcid.org/0000-0002-7535-890X
Liuxiang WangThe Second Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.ORCID https://orcid.org/0009-0004-8436-0720
Guangyu FuZhengzhou Auto Bioengineering Co., Ltd., Zhengzhou, China.ORCID https://orcid.org/0009-0001-6450-3454
Yehuan ZhengZhengzhou Auto Bioengineering Co., Ltd., Zhengzhou, China.ORCID https://orcid.org/0000-0003-1996-8153
Chunxia WangThe Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, China.ORCID https://orcid.org/0000-0002-4059-0012
Zhentao WangThe Second Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.ORCID https://orcid.org/0009-0001-6066-3469
Yongwei LiThe Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, China.ORCID https://orcid.org/0000-0003-2297-8934

Funding

the Henan Provincial Science and Technology Research Project 252102311164the Henan Provincial Science and Technology Research Project 262102310215the Key Scientific Research Project of Henan Higher Education Institutions 24A310007the Key Scientific Research Project of Henan Higher Education Institutions 25A320042the Special Research Project of Traditional Chinese Medicine of Henan Province 2025LHZ2022the Wu Jieping Medical Foundation Research Special Fund 320.6750.2024-03-27
6 · The paper itself

Abstract

Mixed-species biofilms formed by carbapenem-resistant Klebsiella pneumoniae and carbapenem-resistant Acinetobacter baumannii can complicate the clinical management of device-associated infections; however, phage-based interventions targeting these communities remain insufficiently characterized. We assessed the antibiofilm activity of a lytic HZJ31 + HZY2308 phage cocktail against KPZ2-AB48 mixed-species biofilms. Compared with the corresponding single-species cultures, cocultures showed greater crystal violet-stained biomass, higher metabolic activity as measured by the 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) reduction assay, and microscopic surface coverage. Phage-cocktail exposure during biofilm development or after biofilm formation reduced biomass, XTT reduction, culturable bacterial counts, and scanning electron microscopy-derived surface coverage, with similar changes observed on central venous catheter surfaces. In Galleria mellonella infection models, cocktail treatment increased survival and was associated with less extensive histopathological lesions and lower Kirschner wire-associated bacterial burdens. RNA sequencing and quantitative reverse transcription polymerase chain reaction identified treatment-associated transcriptional changes involving metabolic pathways, autoinducer-2 transport, cell-envelope functions, efflux systems, and stress responses. These findings support further preclinical investigation of phage cocktails targeting multidrug-resistant mixed-species biofilms.

Indexed as

Acinetobacter baumanniiBacteriophagesBiofilmsKlebsiella pneumoniaeAnimalsAnti-Bacterial AgentsCarbapenemsGene Expression ProfilingMothsTranscription, GeneticAnti-Bacterial AgentsCarbapenems

Identifiers

PMID42693624
PMCPMC13542435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.